bevacizumab,atezolizumab
roche
['imbrave050', 'bevacizumab', 'bcsm', 'hcc', 'atezo']
imbrave050: recurrence-free survival with adjuvant atezolizumab plus bevacizumab for hcc #hpbcsm #livercancer #hcc #immunotherapy #oncology #aacr23 
News and views from the world of clinical oncology and hematology